RT @BJGPjournal: Methenamine hippurate does not improve prevention of UTIs when compared with placebo or no treatment, and antibiotics. Its…
RT @2weekSR: Now officially published, a previous #2weekSR with @Mina_Bakhit @HilderJoanne and a couple other lovely people :)
RT @BJGPjournal: Methenamine hippurate does not improve prevention of UTIs when compared with placebo or no treatment, and antibiotics. Its…
RT @2weekSR: Now officially published, a previous #2weekSR with @Mina_Bakhit @HilderJoanne and a couple other lovely people :) https://t.co…
Now officially published, a previous #2weekSR with @Mina_Bakhit @HilderJoanne and a couple other lovely people :)
Methenamine hippurate does not improve prevention of UTIs when compared with placebo or no treatment, and antibiotics. Its use may help decrease antibiotic prescribing rates. @Institute4EBH @2weekSR @Mina_Bakhit https://t.co/RTDXY5TWgo https://t.co/ItYZ7v2
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/4bWjijrvK8
RT @TripPrimaryCare: New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review…
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
RT @TripPrimaryCare: New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review…
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
RT @tripdatabase: New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review &…
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/4bWjijrvK8
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
RT @TripPrimaryCare: New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review…
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
RT @tripdatabase: New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review &…
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/4bWjijrvK8
New2Trip: Use of methenamine hippurate to prevent urinary tract infections in community adult women: systematic review & meta-analysis https://t.co/LJ9cAXmKSq
Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis https://t.co/dpELNHTiKI
Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis https://t.co/zOjJlXW9L7
RT @BJGPjournal: UTIs: Methenamine hippurate does not improve prevention of UTIs when compared with placebo or no treatment, and antibiotic…
RT @gchlthpapers: Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-a…
Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis https://t.co/T7FDBt0w4L
Another #2weekSR published 😆Hiprex has a non-statistically sig benefit for the no. of patients remaining asymptomatic (vs antibiotic and vs control at 12 months); non-stat signif benefit for abacteriuria (vs antibiotic). @Mina_Bakhit @HilderJoanne @Institu
UTIs: Methenamine hippurate does not improve prevention of UTIs when compared with placebo or no treatment, and antibiotics. However, its use may help decrease antibiotic prescribing rates. @Institute4EBH @2weekSR @Mina_Bakhit https://t.co/RTDXY5TWgo
RT @HilderJoanne: For me, the only way to learn how to do a systematic review, was to do one. I’m thankful for the @2weekSR people for havi…
For me, the only way to learn how to do a systematic review, was to do one. I’m thankful for the @2weekSR people for having me on the team. Now, how do we provide this opportunity to other health professionals?
Another #2weekSR published: Hiprex for UTIs. 6 RCTs with 557 participants, non-significant trend of benefit vs antibiotics (at 12 mo) & vs control (6-12 mo), for the number of patients remaining asymptomatic. @Mina_Bakhit @HilderJoanne https://t.co/D